Research for June 2, 2021
advertisement
- Real-World Evidence of the Incidence of and Risk Factors for Type 1 Diabetes Mellitus and Hypothyroidism as Immune-Related Adverse Events Associated With Programmed Cell Death-1 Inhibitors (HTML)
- A Conditional Generative Adversarial Network for Synthesis of Continuous Glucose Monitoring Signals (HTML)
- Differences in Maturation Status and Immune Phenotypes of Circulating Helios + and Helios – Tregs and Their Disrupted Correlations With Monocyte Subsets in Autoantibody-Positive T1D Individuals (HTML)
- A Strategy to Simultaneously Cure Type 1 Diabetes and Diabetic Nephropathy by Transplant of Composite Islet-Kidney Grafts (HTML)
- A New Hypothesis for Type 1 Diabetes Risk: The At-Risk Allele at rs3842753 Associates With Increased Beta-cell INS Messenger RNA in a Meta-Analysis of Single-Cell RNA-Sequencing Data (HTML)
- Caries Status and Salivary Alterations of Type-1 Diabetes Mellitus in Children and Adolescents: A Systematic Review and Meta-analysis (HTML)
- US Food and Drug Administration (FDA) Panel Endorses Islet Cell Treatment for Type 1 Diabetes: A Pyrrhic victory?
- Dasiglucagon: First Approval (HTML)
- Galectin-3 Binding Protein, Depression, and Younger Age Were Independently Associated With Alexithymia in Adult Patients With Type 1 Diabetes (HTML)
- Cesarean delivery and risk of hospitalization for autoimmune disorders before 14 years of age (HTML)
- Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study (HTML)
- Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes (HTML)
- Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses (HTML)
